MGRX logo

MANGOCEUTICALS INC

MGRXNASDAQ
🏆 #5063 by market capUS Equity
$0.45▲ $0.09 (+21.09%)
After hours · at close
🔔
Track MGRX
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 21.1%
7d▲ 8.4%
14d▲ 6.5%
30d▲ 12.6%
ytd▼ 36.5%
1y▼ 78.8%
🏦Market Cap
$8M
Small Cap
📈Revenue Growth (YoY)
-38.9%
Declining
📊Gross Margin
54.4%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
31.9x
Expensive
Otter Score
84
Good

Trading Snapshot

Day Range
$0.45 – $0.45
52-Week Range
$0.16 – $2.75
Volume
$5.20B
Avg Volume
$4.80B
Shares Outstanding
17.2M
Next Earnings
Nov 19, 2026

Fundamentals Snapshot

Annual Revenue
$260,302
Last Q Revenue
$72,606
P/E Ratio
—
P/S Ratio
31.9x
EPS (TTM)
$-1.14
Dividend Yield
—

Why Investors Own MGRX

  • ✓High-growth profile — revenue up +47.4% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 73% gross margin and 28% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MGRX logo

MANGOCEUTICALS INC

MGRX
Financial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$260,302▲ +46.6% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
72.5%▲ +2.5% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$53,622▲ +46.6% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$73,665▲ +46.6% YoY
StockOtter · stockotter.space

About MANGOCEUTICALS INC

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
84/100

Analyst Price Target

ⓘ
Average Target
$0.53
▲ +19.1% Upside
High Target$0.59
Low Target$0.49
Based on 9 analysts

Latest News & Updates

🚀
Reuters·2h ago

MANGOCEUTICALS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift MGRX price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

MANGOCEUTICALS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.